CompletedNo phase
Brief Cognitive Behavioral Therapy to Enhance Benzodiazepine Deprescribing
Key facts
- Who runs it
- Beth Israel Deaconess Medical Center
- Where
- Boston, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 17 people enrolled
- Started
- 8 Nov 2023
- Ended
- 8 Jun 2025
- Type of study
- Interventional
- Treatments tested
- Benzodiazepine Medication Taper with Cognitive Behavioral Therapy
- Record updated
- 4 February 2026
Who can take part
- Age
- 55 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Prescribed chronic benzodiazepines by their primary care clinicians at a Beth Israel Deaconess Medical Center (BIDMC) Primary Care Clinic
Who cannot take part
- Primary Care Practitioner (PCP) opt out
- Severe anxiety or depression symptoms
Where in United States
- Beth Israel Deaconess Medical CenterBoston, United StatesNo longer taking part
About the trial
What the trial wants to find out
The goal of this clinical trial is to conduct a single-arm pilot trial of a brief cognitive-behavioral therapy-enhanced benzodiazepine deprescribing intervention in 20 older adults (aged ≥55 years) prescribed chronic benzodiazepines by their primary care clinicians.
The group in the trial
- Benzodiazepine Medication Taper with Cognitive Behavioral TherapyTreatment being tested
Brief Cognitive Behavioral Therapy to Enhance Benzodiazepine Deprescribing
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Pilot of a Brief Cognitive Behavioral Therapy Intervention to Enhance Benzodiazepine Deprescribing in Older Adults
- Record updated
- 4 February 2026